Authors: Holford, J Beale, PJ Boxall, FE Sharp, SY Kelland, LR

Citation: J. Holford et al., Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines, EUR J CANC, 36(15), 2000, pp. 1984-1990

Authors: Sharp, SY Kelland, LR Valenti, MR Brunton, LA Hobbs, S Workman, P

Citation: Sy. Sharp et al., Establishment of an isogenic human colon tumor model for NQO1 gene expression: Application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo, MOLEC PHARM, 58(5), 2000, pp. 1146-1155

Authors: Beale, PJ Rogers, P Boxall, F Sharp, SY Kelland, LR

Citation: Pj. Beale et al., BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma, BR J CANC, 82(2), 2000, pp. 436-440

Authors: Kelland, LR Sharp, SY Rogers, PM Myers, TG Workman, P

Citation: Lr. Kelland et al., DT-diaphorase expression and tumor cell sensitivity to 17-allylamino,17-demethoxygeldanamycin, an inhibitor of heat shock protein 90, J NAT CANC, 91(22), 1999, pp. 1940-1949

Authors: Hiorns, LR Seckl, MJ Paradinas, F Sharp, SY Skelton, LA Brunstrom, G Newlands, ES Kelland, LR Leyland-Jones, B

Citation: Lr. Hiorns et al., A molecular cytogenetic approach to studying platinum resistance, J INORG BIO, 77(1-2), 1999, pp. 95-104

Authors: Kelland, LR Sharp, SY O'Neill, CF Raynaud, FI Beale, PJ Judson, IR

Citation: Lr. Kelland et al., Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance, J INORG BIO, 77(1-2), 1999, pp. 111-115